The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol

Proprotein convertase subtilisin/kexin type 9 (PCSK9) directly binds to the epidermal growth factor-like repeat A domain of low-density lipoprotein receptor and induces its degradation, thereby controlling circulating low-density lipoprotein cholesterol (LDL-C) concentration. Heterozygous loss-of-fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Poirier, Steve, Mayer, Gaétan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793591/
https://www.ncbi.nlm.nih.gov/pubmed/24115837
http://dx.doi.org/10.2147/DDDT.S36984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793591/
https://www.ncbi.nlm.nih.gov/pubmed/24115837
http://dx.doi.org/10.2147/DDDT.S36984

Ejemplares similares